Few details on the agreement but great to see things moving forward #idsky #endtb pharma.economictimes.indiatimes.com/amp/news/pha...

Hoy la Comisión de Salud Pública del Parlamento Europeo debate las enmiendas a la nueva Ley de Medicamentos Críticos. La analizamos en esta tribuna de @agendapublica.es agendapublica.es/noticia/2047...

China leads research in 90% of crucial technologies — a dramatic shift this century www.nature.com/articles/d41...

An update of how the total exclusivity period would look like in the EU after the provisional agreement of the pharma package. It is not the best scenario, but still we might see generics entrying the market sooner that in the current system

Here we go with a quick analysis

On transparency , this is the agreement. Parliament did not manage to get its ammendment on transparency on INDIRECT funding (which is the main funding they get in the EU) @rozscourse.bsky.social

Habemus new pharmaceutical legislation in the EU www.consilium.europa.eu/en/press/pre... @thirugeneva.bsky.social @healthlawadamh.bsky.social @mattherder.bsky.social

Along with 10 other civil society organisations, we sent an open letter to the European Parliament’s Committee on Public Health, sharing recommendations to ensure that the Critical Medicines Act advances equitable access for all. msfaccess.org/cso-open-let...

Must read "This pressure to buy companies before competitors do, to be ahead of a patent cliff, has led to a rise in the amount paid for the acquisition of companies. In turn, this has increased pressure to inflate the prices of drugs to match higher acquisition costs." www.somo.nl/the-power-to...

The Golden Age of Corporate Access — in an Era of Civil Society Defunding 🧵 A quick thread on what declared meetings show around the EU’s Critical Medicines Act.

🇪🇺 #Lobbying: How Europe’s #Business lobby took over the European Commission The EU’s regulatory 'simplification' drive is turning into a bonanza for corporate lobbyists at the expense of #CivilSociety groups focused on areas such as the #Environment and #Health www.euractiv.com/news/counter...

Today, 11 CSO sent a letter to MEPs: the Critical Medicines Act must put people first. We urge them to strengthen joint procurement to improve affordability and availability, guarantee a public return on public investment, and align EU pharmaceutical policy with global health commitments.

Latest CHAI HIV Market Report: 📉 26,000 children with HIV missing from care 📉 PrEP initiations ↓37% 📉 HIV testing ↓8% 📉 New diagnoses ↓22% 📉 Adult loss-to-follow-up ↑10% and in the meantime we are witnessing this unjustified regulatory strategy for LEN with many left behind #idsky

Noruega demostró que una transición a una cuota de mercado 100% eléctrica se puede hacer en 10 años. Dinamarca demostrará que se puede hacer en menos. Cambiar la fecha de 2035 para prohibir la venta de vehículos de combustión es un error.

Hoy es el #DiaMundialDelSida y más que nunca hace falta tratarlo como problema global Escribo con Phillipe Duneton @unitaid.bsky.social en @eldiario.es sobre cómo hacer que se alineen las acciones necesarias para que el VIH deje de ser una preocupación global www.eldiario.es/opinion/trib...

En muchos campos además (por ejemplo en CAR-T / terapias avanzadas), y con estrategias de monopolio que hasta la fecha no sabemos si difieren o no de las que los países de altos ingresos han venido esgrimiendo los últimos siglos. /1 www.transparimed.org/single-post/...

Para ver esto en un marco global - "IMF projects that eliminating post-tax subsidies for the most-polluting energy fuels, such as coal and gasoline, could raise government revenue by $2.9 trillion, while also slashing premature deaths from pollution-related diseases by more than 50 percent."

Great news! Secondary patents on bedaquiline remain in effect in the EU, the main reason for its exorbitant prices #endTB

Vietnam has revoked most of J&J’s patent claims on the TB drug bedaquiline which is a major win for affordable treatment and against patent evergreening. J&J has 90 days to appeal. Lives must come before profits. makemedicinesaffordable.org/mma-partner-... #MakeMedicinesAffordable #EndTB

Wouldn’t this have been the perfect moment to ask for something in return for public money ? Not only EMA has granted orphan designation to AlpE, but quick search on public funding granted to this: /1 www.ihi.europa.eu/news-events/...

Ahora en la UE tenemos la oportunidad de hacer el trabajo en casa, y las negociaciones para el próximo presupuesto a largo plazo de la UE son el terreno. El dinero público de la UE que se destina a los combustibles fósiles se viene manteniendo estable en ~€56 mil millones (2015-2022) /1

5 apuntes sanitarios para terminar la semana. 🔸Evento OMS-Euro sobre violencia de género y sanidad 🔸APREM, SECPAL y el trabajo social 🔸Uso Prudente de Antibióticos 🔸Jornada Menudos Corazones 🔸Racismo y salud pública t.me/agranescala/...

Perhaps this time it is genuinely happening, and the EU (and the next MFF) seems like the most appropriate place to start. @htejero.bsky.social @xanlopez.xyz @esantiago.bsky.social

España necesita una prestación universal por crianza. Por justicia social, por eficacia económica y por sentido común.

In line with the impact of ODA "Savings", this new analysis by ISGlobal www.isglobal.org/documents/d/... . Higher ODA is linked to: • 23% fewer deaths overall • 39% fewer deaths in children under five • HIV/AIDS related deaths drop by 70% • Malaria deaths drop by 56% • NTDs drop by 54% /1

"Strengthening #TB diagnostic capacity in the EU/EEA is therefore essential, particularly considering rapid technological progress, emerging drug resistance, lower success rate of DR-TB treatment,1 and ongoing migration from high-burden countries. " I agree BUT ...👇 www.thelancet.com/journals/lan...

Accelerate action should also mean addressing the barriers to access #HPV vax accross the globe #idsky #Medsky🧪 👇 www.who.int/news/item/17...

In the 50 years before 2021, there were 13 outbreaks - since 2021, this is like the 5th outbreak or so? I wonder whether usaid cuts have affected vaccine candidate development somehow (Sabin Vax Institute?) www.afro.who.int/countries/et... #idsky

En detalle, en 2025 EEUU ya produce casi tanto petróleo ¡como Arabia Saudí y Rusia juntas! Por no hablar del gas (chao pikoilers). Esto son billones -europeos- de dólares que no van a dejarse extinguir ni por la amenaza climática ni por la emergencia de una forma energética superior. Pelearán.

El problema más importante es cómo esta visión apocalíptica top-down, de gente con mucho poder social y mediático, se mezcla y se confunde con las quejas legítimas de otra parte de la sociedad que sí puede decir que las cosas no le van bien. Por ejemplo, los que no tienen casa en propiedad.

France is killing it - net price transparency now, ammendment tabled and adopted ! @healthlawadamh.bsky.social @mattherder.bsky.social

"Although WHO prequalification of the RSVpreF vaccine single-dose vial marked a turning point for global #RSV prevention, [preQ] for mAbs might be challenging at the current expected procurement price, as high cost restricts financing support" www.thelancet.com/journals/lan... #IDSky #MedSky

But no earmarked funding yet available for #tuberculosis vaccine procurement (and an existing TB funding gap of US$16.3 billion in 2024) iris.who.int/server/api/c...

Arm twisting by the US government is going to another extreme by tying funding aid to the condition of pathogen sharing. While this sharing will not be attached to condition to access medical tools that are developed from the pathogen information that countries would share.

Important development in France for those following #pharma #transparency. Socialist MPs have proposed an amendment to the 2026 Social Security Financing Bill that could redefine transparency in how medicines are financed and priced. /1🧵 www.assemblee-nationale.fr/dyn/17/amend...

A new study @fr.publiceye.ch shows Roche’s patent "evergreening" strategy for its HER2+ breast cancer drugs (Herceptin & Co), enabling it to rake in >CHF 156 bn & hinder timely access to affordable biosimilars until 2042. 👉 Time for 🇨🇭 to act against patent thickets www.publiceye.ch/en/topics/ph...

"Into the breach a clamor for the financialization of the global health industry resounds. Speculative finance is gaining ground. [...] What will investors buy? What is their loss tolerance? Left behind are the most important questions: Are lives being saved? Are people getting healthier?"

After a long process, our article — written with @mbabeenchama.bsky.social and a formidable team incl @daniellaparra.bsky.social — has just been published It explores how racism operates as an invisible but powerful determinant of health in Spain. ojs.sanidad.gob.es/index.php/re...

[...] the available indirect evidence supports the existence of plausible causal links between climate change and tuberculosis. This evidence highlights the need to [...] include tuberculosis in climate risk adaptation and mitigation programmes #EndTB #tuberculosis www.thelancet.com/journals/lan...

Fascinating piece!

Horrific details emerging from El Fasher, Sudan: pools of blood so large they’re visible by satellite, people being killed systematically. Last week, MSF teams assessed 165 children under 5 fleeing the area and found 75% were acutely malnourished. An accelerating genocide before our eyes.

An article opening "The last outbreak of #cholera in Britain was in 1866; in the United States there has not been an outbreak since 1911", shouldn't then ignore the thriving parallel market for cholera vaccines for travellers from rich countries. Market only failing those needing it most. Our view:

Its happening today.

A strong case by Lucy Xiaolu Wang for why clinical trial data should be part of the patent examination process. theconversation.com/some-new-dru...

TB anywhere is TB everywhere. Join us to know the challenges people with TB continue to face in accessing the TB treatment in EU and EEA region. #TBSky #IDSky

🚨 We demand urgent action: Expand the $40 lenacapavir price to all LMICs, not just those chosen by Gilead. Use TRIPS flexibilities, support local generics, & fund universal, not selective, access. makemedicinesaffordable.org/no-borders-n... #MakeMedicinesAffordable

What do we talk about when we talk about ... conditionalities? "in 2021, Sanofi received $415 million in federal funds to build a flu vaccine–manufacturing plant in Canada. This deal could perhaps have included a requirement to apply for approval of rifapentine with Health Canada."

Impressive panel assembled by @msfaccess.org for this upcoming virtual event on "Bridging the gap: Securing access to essential TB medicines in the EU and EEA" ⚖️💊 Registration: us06web.zoom.us/webinar/regi... #MSF report on the topic: msfaccess.org/bridging-gap...

This week’s announcement set the price of lenacapavir at the level of oral PrEP. This is a major step forward for HIV prevention. 🌍💊 But there’s a big problem: Gilead is restricting access by limiting its license to certain countries.